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Systemic circulatory influences on retinal microvascular function in middle-age 
individuals with low to moderate cardiovascular risk 
 
Swathi Seshadri, Stephanie Mroczkowska, Lu Qin, Sunni Patel, Aniko Ekart & Doina 
Gherghel. 
 
Abstract 
 
Purpose: To investigate the relationship between retinal microvascular reactivity, circulatory 
markers for CVD risk and systemic anti-oxidative defence capacity in healthy middle-aged 
individuals with low to moderate risk of CVD. 
Methods: Retinal vascular reactivity to flickering light was assessed in 102 healthy 
participants (46-60 years) by means of dynamic retinal vessel analysis (DVA). Other 
vascular assessments included carotid intima-media thickness (C-IMT) and blood pressure 
(BP) measurements. Total cholesterol (CHOL), high-density lipoprotein cholesterol (HDL-C), 
and low-density lipoprotein cholesterol (LDL-C), triglycerides (TG) and blood glutathione 
levels in its reduced (GSH) and oxidized (GSSG) forms were also determined for each 
participant, along with Framingham risk scores (FRS).  
Results: Retinal arterial baseline diameter fluctuation (BDF) was independently, significantly 
and negatively influenced by LDL-C levels (β=-0.53, p=0.027). Moreover, the arterial dilation 
slope (SlopeAD) was independently, significantly and positively associated with redox index 
(GSH: GSSG ratio, β=0.28, p=0.016), while the arterial constriction slope (SlopeAC) was 
significantly and negatively influenced by blood GSH levels (β=-0.20, p=0.042), and 
positively associated with FRS (β=0.25, p=0.009). Venous BDF and dilation amplitude (DA) 
were also negatively influenced by plasma LDL-C levels (β=-0.83, p=0.013; and β=-0.22, 
p=0.028, respectively).   
Conclusions: In otherwise healthy individuals with low to moderate cardiovascular risk, 
retinal microvascular dilation and constriction responses to stress levels are influenced by 
systemic antioxidant capacity, and circulating markers for cardiovascular risk. 
 
Key words: oxidative stress, retina, vascular function, cardiovascular risk, dynamic retinal 
vessel analysis 
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Introduction 
 
Functional assessments of microvessels are of particular clinical interest since endothelial 
dysfunction, one of the main culprits for the development of atherosclerosis, is thought to 
occur much earlier at the microvascular than at the macrovascular level (Gariano &  Gardner 
2005; Gates et al. 2009). Consequently, several methods have been developed to assess 
functional responses in various microvascular beds. Among those, dynamic retinal vessel 
analysis (DVA) was recently identified as a useful measure of early changes that signal 
endothelial dysfunction and risk for future cardiovascular pathologies in individuals with and 
without overt disease (Nagel &  Vilser 2004; Nagel et al. 2006; Mandecka et al. 2007; Bek et 
al. 2008; Heitmar et al. 2010; Patel et al. 2011; Mroczkowska et al. 2012; Patel et al. 2012; 
Qin et al. 2013). This is generally possible due to the fact that the retinal microvascular 
response to flicker provocation is, in part, dependent on nitric oxide (NO) release, (Dorner et 
al. 2003) and compromised NO homeostasis is known to be a key factor in endothelial 
dysfunction at all vascular levels. However, other mechanisms such as altered metabolic 
demand and neurovascular coupling are also largely involved in the retinal vascular 
response to flickering light (Lim et al. 2012). Indeed, we have already demonstrated that 
retinal microvascular function as measured by DVA is affected in patients with Alzheimer’s 
disease, a pathological process largely associated with disturbed neurovascular coupling. 
(Mroczkowska et al. 2013). Nevertheless, it has been hypothesized that abnormal 
neurovascular coupling in such context could also represent a direct consequence of 
endothelial dysfunction (Lim et al. 2012). 
At the systemic level it is known that degradation of NO by free radicals generated during 
oxidative stress may impair vasodilation (Cines et al. 1998), and therefore result in vascular 
dysfunction. The human body uses a complex anti-oxidative defence mechanism involving 
glutathione among other factors to combat stressors such as high oxygen flux. 
Consequently, any condition associated with low levels of circulating glutathione result in a 
higher rate of oxidative reactions that contribute towards low NO bioavailability, with 
important consequences on the normal regulation of systemic haemodynamics (Vallance &  
Chan 2001). In parallel, it is also known that abnormal lipid metabolism and insulin 
resistance are linked to microvascular endothelial dysfunction and increased cardiovascular 
disease (CVD) risk. The combined effect of low glutathione and abnormal circulating lipids 
could therefore amplify endothelial dysfunction at all vascular levels, including the retinal 
vessels (Patel et al. 2011; Qin et al. 2013). This possibility may be important for screening 
and early intervention, particularly in individuals free of overt vascular disease, but who 
belong to a group when age-induced cardiovascular complications start to occur. Indeed 
previous reports indicate that nearly 50% of individuals who suffer a fatal cardiovascular 
event had not received a positive diagnosis or displayed symptoms prior to death (Gallino 
2012). Despite this, traditional risk factor estimates such as Framingham risk scores (FRS) 
are still largely used for disease prognosis. It is known, however, that the FRS can either 
over- or under-estimate actual risk in a large number of individuals (Cohn 2013). As other 
more sensitive biomarkers emerge (Vasan 2006; Helfand et al. 2009; Wang 2011; Ge &  
Wang 2012), it seems that using these in addition to the FRS could increase the likelihood of 
early CVD detection (Wannamethee et al. 2005; Mattace-Raso et al. 2006; Fowkes et al. 
2008; Kavousi et al. 2012). This represents an important need in the current concept of 
prediction, prevention, and personalised interventions that target individualized risk for 
certain diseases (Harvey et al. 2012). Following the trend of modern research, 
cardiovascular medicine has also embraced the study of “omics” (genomics, metabolomics, 
proteomics) (Ge &  Wang 2012) where detailed biological profiling of individuals rather than 
population groups has been crucial in initiating the move to personalised medicine. Since 
biomarkers that form an important component of these strategies comprise anything from 
genetic markers to imaging tests, functional microvascular assessments could also provide 
integrated and dynamic data to aid in establishing a new CVD risk indicator for each 
individual. We have already demonstrated that assessing retinal microvascular function is an 
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easy, non-invasive method demonstrated to offer early detection of vascular risk in 
asymptomatic individuals (Patel et al. 2011). Nevertheless, a better understanding of a 
possible relationship between established biomarkers of CVD risk, and microvascular retinal 
function in individuals with low to intermediate CVD risk is still needed. The aim of the 
present study is therefore to investigate the influences that circulatory markers for CVD risk 
and systemic anti-oxidative defence capacity have on retinal microvascular reactivity, in 
healthy middle-aged individuals with low to intermediate risk of CVD.  
 
Methods 
 
Study participants 
 
Healthy individuals over the age of 40 were recruited through advertisements at the Vascular 
Research Laboratory, Aston University (Birmingham, UK) for inclusion in this prospective 
study. Ethical approval was sought from the relevant local ethics committee and written 
informed consent was received from all participants prior to study enrollment. The study was 
designed and conducted in accordance with the tenets of the Declaration of Helsinki and all 
study-related procedures adhered to institutional guidelines.  
Study exclusion criteria were defined as the positive diagnosis of cardiovascular disease, 
(coronary artery disease, heart failure, arrhythmia, stroke, transient ischaemic attacks), 
cerebrovascular disease, peripheral vascular disease, severe dyslipidaemia (defined as 
plasma triglycerides > 6.00mmol/L or cholesterol levels > 7.00mmol/L), diabetes, as well as 
other metabolic disorders or chronic diseases that required treatment. Frequent use of 
vasoactive medications such as dietary supplements containing vitamins or antioxidants and 
bronchodilators also served as exclusion criteria. Potential participants were also screened 
for ocular diseases and were excluded from the study if they had a refractive error of more 
than ±3DS and more than ±1DC equivalent, intra-ocular pressure (IOP) greater than 21 
mmHg, cataract or any other media opacities, as well as history of intraocular surgery or any 
form of retinal or neuro-ophthalmic disease affecting the ocular vascular system. 
General investigations 
Participants who met the inclusion criteria were requested to complete a general health 
history questionnaire, also detailing daily diet, physical activity, and alcohol consumption. All 
study-related measurements were performed between 8 and 11 am following a 12-hour 
overnight fast, which included refraining from alcohol and caffeine.  
 
Standard anthropometric measures of height and weight were recorded to determine body 
mass index (BMI= weight/height²). Systolic blood pressure (SBP), diastolic blood pressure 
(DBP) and heart rate (HR) were measured using an automatic BP monitor (UA-767, A & D 
Instruments Ltd, UK) and IOP readings were obtained using non-contact tonometry (Keeler 
Pulsair, UK).  
 
Carotid intima-media thickness 
 
Intima-media thickness measurements of the left and right common carotid arteries were 
obtained for all participants in accordance with an already published protocol (Salonen et al. 
1991). Briefly, each patient was positioned in supine position and a high-resolution B-mode 
ultrasound system (Siemens, Acuson-Sequoia, UK) was used to capture an image of the 
right then left carotid artery at the level of the carotid bifurcation. C-IMT measurements were 
then taken from the central region of the inferior arterial wall using the in-built software 
caliper system, at a site proximal to the artery bifurcation.  
 
Dynamic retinal vessel analysis  
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Retinal vessel reactivity was assessed using the dynamic retinal vessel analyser (DVA, 
IMEDOS GmbH, Jena, Germany) in accordance with an established protocol (Nagel et al. 
2005). All measurements were performed in a temperature controlled environment (22oC) 
following pupil dilation with 1% Tropicamide (Chauvin Pharmaceuticals Ltd, UK), and were 
taken from the inferior temporal vessel branches approximately one and a half disc 
diameters from the optic nerve head of one unselected eye. The flicker stimulation protocol 
involves a 350-second continuous diameter recording along short 1mm sections of the retinal 
vasculature, the duration of which included a 50-second baseline measurement followed by 
three successive cycles of flicker stimulation distinguished as a 20-second stimulus (opto-
electronically generated at 12.5Hz) and an 80-second recovery period (still illumination). The 
following retinal vessel reactivity and time course parameters, collectively known as 
Sequential and Diameter Response Analysis (SDRA) (Heitmar et al. 2010), were then 
calculated. The differences between the maximum and minimum baseline vessel diameter 
was termed as baseline-diameter fluctuation (BDF), the maximum diameter (MD) was used 
to describe the maximal vessel dilation in response to flicker light stimulation expressed as a 
percentage relative to baseline, the time taken (seconds) to reach the maximum vessel 
diameter during flicker exposure was termed as MD reaction time (tMD), the minimal vessel 
diameter during the recovery period was used to determine the maximum vessel constriction 
and calculated as a percentage relative to baseline and expressed as the maximum 
constriction (MC) whilst the time taken (seconds) to reach maximal vessel constriction was 
termed maximum constriction reaction time (tMC), and the difference between maximal 
dilation and constriction responses was termed as the dilation amplitude (DA). In addition, 
the nature of the entire dynamic vessel response profile for both arteries (A) and veins (V) 
was explored using high-level programming language functions in Matlab (Version 2010a; 
MathWorks Inc., Natick, MA), as detailed previously (Mroczkowska et al. 2012), to determine 
dilation slope (SlopeAD/VD = MD-baseline diameter/tMD) and constriction slope (SlopeAC/VC = 
MC-MD/tMC), defined as the interaction between the change in vessel diameter and the rate 
at which this change occurs.  
 
Biomarker Assays 
Bloods samples drawn from the ante-cubital fossa vein on the morning of the appointment 
were collected into standard EDTA Vacutainer ® tubes and assessed immediately for fasting 
triglycerides (TG), plasma total cholesterol (CHOL) and high-density lipoprotein cholesterol 
(HDL-C) using the Reflotron Desktop Analyser (Roche Diagnostics, UK). Low-density 
lipoprotein cholesterol (LDL-C) values were calculated as per the Friedewald equation 
(Friedewald et al. 1972). 
 
Glutathione recycling assay 
 
Blood collection, initial processing, and processing for the glutathione recycling assay were 
as detailed previously (Gherghel et al. 2013). Briefly, a 30µL aliquot of EDTA blood was pre-
treated with 33.3 μL of 100 mg/mL 5-sulfosalicylic acid (SSA), 936.7μL sodium phosphate 
buffer (pH 7.5) to release GSH via cellular disruption and protein precipitation. The sample 
was centrifuged at 13,000 rpm for 5 minutes, and the supernatant was stored at -80oC for 
further analyses. Based on previous reports of sample stability, assays were conducted 
within 2 months of collection (Jones et al. 1998).  The GSH levels [t-GSH – (2 x GSSG)] and 
the redox index (defined as the GSH/GSSG ratio) were determined according to an 
established enzymatic recycling assay (Tietze 1969; Anderson 1996) that involves the 
oxidation of GSH by the sulfhydryl reagent 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB) to 
form the yellow derivative 5'-thio-2-nitrobenzoic acid (TNB), which can be measured 
spectrophotometrically at 412 nm. Any GSSG formed was recycled to GSH by glutathione 
reductase (GSR) in the presence of nicotinamide adenine dinucleotide phosphate-oxidase 
(NADPH). For the measurement of GSSG levels samples were pre-treated with, 2-
vinylpyridine (2VP) in order to derivatize GSH without interfering with GSR reaction.  For the 
  6
determination of analyte concentrations in the samples, GSH standards were prepared from 
0 to 80 µM in increments of 20 µM and GSSG standards were prepared from 0 to 10 µM in 
increments of 1 µM with the same final concentrations of SSA (1%) as in the samples. 
Standard curves were generated using a linear regression program (Microsoft Excel, 
Microsoft Corporation, USA). Since the microplates were read at 0, 1, 2, 3, and 5 minutes, 
the change in optical density or absorbance at different times points expressed against GSH 
or GSSG concentration (net reaction rate = slope * GSH or GSSG concentration + intercept) 
was used to determine GSH or GSSG concentrations in the samples (net rate – intercept / 
slope * dilution factor). The blood GSH and GSSG concentrations measured in this study 
were in good agreement with literature data in control patients in the ranges of 150 – 1500 
µM and 1 to 500 µM, respectively (Rossi et al. 2002; Gherghel et al. 2005; Gherghel et al. 
2013). This suggests that the experimental conditions reported in this study are suitable for 
the analysis of total glutathione and glutathione disulphide concentrations in whole blood. 
The validity and reliability of the spectrophotometric method of detection has also previously 
been established (Rahman et al. 2006).    
 
Framingham Risk Score (FRS) 
 
At present the conventional approach for cardiovascular risk assessment endorses the use 
of multivariable risk score calculations to estimate an individual’s 10-year or lifetime risk of 
developing CVD.  The FRS is a widely used gender-specific algorithm originally developed to 
estimate CVD risk (Wilson et al. 1987). In the present study FRS was calculated using the 
current version of the FRS published by an expert panel of the National Heart, Lung and 
Blood Institute (NHLBI) (2002) and is based on risk factors such as age, gender, CHOL, 
HDL-C, SBP, treatment for hypertension, smoking status, and diabetes. Risk factors such as 
age, treatment for hypertension, smoking status and diabetes were identified from self-report 
questionnaires and CHOL, HDL-C, and SBP values were as those determined on the day of 
study assessment. The scoring algorithm is based on gender-specific points assigned for 
each risk factor variable that can be determined using FRS tables i.e. point scores by age 
group; age group and total CHOL; age group and smoking status; HDL-C level; SBP and 
treatment status. Ten-year risk percentage is then calculated by total points (1 point, 6%; 2 
points, 8%; 3 points, 10%; 4 points, 12%; 5 points, 16%; 6 points, 20%; 7 points, 25%; 10 
points or more, > 30%). Absolute CVD risk percentage over 10 years was classified as low 
risk (< 10%), intermediate risk (10-20%), and high risk (> 20%) (Ford et al. 2004).  
Sample Size and Statistical analysis 
Based on previous studies, a change of 30% with a SD of 2.5% in retinal vessels reactivity 
was shown to be significant (Garhofer et al. 2004; Patel et al. 2012). As the study design 
was multifactorial in nature it was calculated that a sample size of n = 95 was sufficient to 
provide 95% power at an alpha-level of 0.05. 
All statistical analyses were performed using Statistica® software (StatSoft Inc.; Version 9, 
USA). Distributions of continuous variables were determined by the Shapiro-Wilks test. In 
cases where normality of the data could not be confirmed appropriate data transformations 
were made or non-parametric statistical alternatives were used. Group differences were 
assessed using the Student’s t-test for independent variables (normal distributions). 
Univariate associations were determined using Pearson’s (normally distributed) or 
Spearman’s method (non-normally distributed), and forward stepwise regression analyses 
were performed to test the influence of age, BMI, SBP, DBP, HR, IOP, C-IMT, and 
circulating markers on the measured variables.  Data are expressed for normally distributed 
variables as mean ± standard deviation (SD) or non-normally distributed variables as 
median with inter-quartile range (IQR). In multivariate regression models the β coefficient 
value was considered to answer the question of which of the independent variables has a 
greater effect on the dependent variable as β refers to the SD change in the dependent 
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variable per SD increase in the predictor variable, and is particularly useful when variables 
are measured in different units. A p-value of <0.05 was considered as statistically significant.  
Results 
One hundred and two healthy participants with low to intermediate global cardiovascular risk 
(<20 % at 10 years as assessed by the FRS) and similar dietary habits were included in the 
final analysis.  
 
Table 1 shows the clinical characteristics of the study population, stratified by gender. Men 
exhibited higher DBP (p = 0.002), and FRS (p < 0.001), and lower total CHOL (p = 0.001), 
and HDL-C (p < 0.001). There were no significant gender differences in age, SBP, HR, IOP, 
BMI, TG, LDL-C, and C-IMT. Although in our sample, women had lower levels of GSSG (p = 
0.030), there were no significant gender differences in the redox index (GSH: GSSG), total 
(tGSH) or reduced glutathione (GSH).  
 
With regards to arterial and venous retinal vascular reactivity parameters as characterized in 
Table 2, all values reported are based on averaged data across three flicker cycles with the 
artery and vein regarded separately. There were no significant differences between male 
and female participants in this study population (all p > 0.05).  
 
Univariate analyses revealed that age correlated significantly and negatively with retinal 
arterial DA (r = -0.24, p = 0.015), and positively with SlopeAC (r = 0.23, p = 0.021).  BMI also 
correlated negatively and significantly with the retinal arterial BDF (r = -0.20, p = 0.040). 
Plasma LDL-C levels correlated negatively and significantly with both arterial BDF and DA (r 
= -0.29, p = 0.004; r = -0.23, p = 0.020, respectively) and venous BDF and DA (r = -0.24, p = 
0.018; r = -0.22, p = 0.028, respectively). Blood GSH levels correlated significantly and 
negatively with SlopeAC (r = -0.24, p = 0.014) and positively with overall retinal arterial DA (r 
= 0.25, p = 0.010), while the redox index similarly positively influenced SlopeAD (r = 0.32, p = 
0.002). The FRS correlated negatively with arterial BDF (r = -0.21, p = 0.035) and positively 
with SlopeAC (r = 0.26, p = 0.010) and SlopeVC (r = 0.22, p = 0.026). 
  
Forward stepwise multiple regression analysis revealed arterial BDF to be independently, 
significantly and negatively influenced by LDL-C (β = -0.53, p = 0.027, Figure 1A) and on the 
venous side BDF and DA were also independently, significantly and negatively influenced by 
circulating LDL-C levels (β = -0.83, p = 0.013; β = -0.22, p = 0.028, respectively, Figure 1B 
and Figure 1C). Also on the arterial side, SlopeAD was independently, significantly and 
positively associated with redox index (β = 0.28, p = 0.016, Figure 2), while SlopeAC was 
significantly and negatively influenced by blood GSH levels (β = -0.20, p = 0.042, Figure 3A), 
and positively associated with FRS (β = 0.25, p = 0.009, Figure 3B).  
 
Discussion 
 
In the present study we examined the relationship between retinal vessel reactivity, systemic 
antioxidant defence capacity and circulating markers of cardiovascular risk in individuals free 
of systemic disease, but with low to moderate FRS for CVD. Systemic ‘redox’ status (GSH: 
GSSG) positively influenced retinal arterial dilation capacity (SlopeAD) during flicker while 
systemic GSH levels negatively influenced retinal arterial constriction capacity (SlopeAC). In 
addition, decreases in arterial and venous BDFs before flicker provocation were identified in 
individuals with increased LDL-C levels. High LDL-C levels also negatively influenced the 
overall retinal venous DA during flicker.  
 
In our study, and in line with previous research (Bolton-Smith et al. 1991; Arsenault et al. 
2009), men exhibited higher BP and FRS as well as lower total CHOL and HDL-C compared 
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to age-matched women. Nevertheless, despite the observed differences there were no 
significant influences of these parameters on retinal vessel reactivity in either gender group.  
 
We also observed lower levels of blood GSSG in women when compared to age-matched 
men. While a number of studies have revealed a relationship between redox balance and 
sex hormone patterns (Capel et al. 1981; Massafra et al. 1998; Diaz-Flores et al. 1999; 
Massafra et al. 2000; Serviddio et al. 2002; Browne et al. 2008; Cornelli et al. 2013), clinical 
reports of gender differences in glutathione levels are inconsistent with some studies 
reporting higher levels of GSH in men (Flagg et al. 1993) and others reporting no gender 
differences in plasma or blood glutathione levels (Michelet et al. 1995). These discrepancies 
may possibly arise due to variations in assay techniques. Our previous reports also reveal 
some degree of variability (Gherghel et al. 2005; Gherghel et al. 2013; Qin et al. 2013) 
however, with the methodology used in our own research being identical, these 
inconsistencies could also be attributed to other factors such as age. Indeed, the present 
study included a slightly younger group than our previous ones (Gherghel et al. 2005; Qin et 
al. 2013). Nevertheless, taken together, these observations suggest that gender might have 
a less consistent effect on blood glutathione levels than other confounding variables 
(Gherghel et al. 2013). Moreover, there were no differences with regards to retinal 
microvascular function parameters between men and women included in our study. 
 
In the present study, we report for the first time a link between retinal arterial dilation during 
stress (SlopeAD) and redox index. From a microvascular standpoint endothelial health and 
redox balance are associative attributes (Frisard et al. 2007; Salmon et al. 2010). Indeed, it 
is well known that excessive levels of reactive oxygen species (ROS) are linked to an 
impaired endothelium-dependent dilation as they seek to quench NO, while the anti-
oxidative properties of GSH involve the scavenging of such free radicals (Ghigo et al. 1993; 
Griscavage et al. 1994; Prasad et al. 1999). Typically, a decrease in the ratio of circulating 
reduced glutathione (GSH) relative to its oxidized form (GSSG) or ‘redox index’ has been 
proposed as an indicator of oxidative imbalance (Blankenberg et al. 2003) and oxidative 
stress status (Jones 2006; Jones 2006; James et al. 2009). Therefore, a positive relationship 
between SlopeAD and redox index, could indicate that in addition to other processes, 
antioxidant mechanisms support normal NO secretion during flicker provocation at the retinal 
microvascular level. This possibility is further emphasised by the other novel discovery of a 
negative relationship between blood GSH levels and SlopeAC. Indeed, thiol oxidations during 
interactions with ROS are associated with endothelial dysfunction and increased 
vasoconstriction (Yamada et al. 2013). This effect has been previously reported at the 
coronary (Yamada et al. 2013), renal (Touyz 2004), and cerebral levels (Ong et al. 2013). 
Similarly, retinal microcirculatory reactivity also seems to be influenced by circulating levels 
of thiols. Interestingly, SlopeAC also correlated with a more traditional risk factor, namely 
FRS. Few other studies have also observed similar relationships between established 
cardiovascular risk scores such as FRS and other measures of vascular function including 
peripheral arterial tonometry (Rubinshtein et al. 2010), digital thermal monitoring (Ahmadi et 
al. 2011), and whole-body MR angiography (Lehrke et al. 2009). Additionally, retinal 
vascular calibres have been shown to be independently associated with risk factor variables 
constituted in the FRS such as age, BP, HDL-C, and LDL-C (von Hanno et al. 2014) which 
are in turn associated with ocular pathologies of vascular consequence such as age-related 
macular degeneration (AMD) (Erke et al. 2014). More recently, semi-automated methods for 
quantitative assessment of the retinal vasculature show promise and may contribute 
additional value to morphological assessments (Schuster et al. 2014). In the present study, 
however, we have demonstrated not only a quantitative relationship between retinal vascular 
function parameters and systemic risk scores, but more specifically, a functional one based 
on the speed and amount of vascular reactivity defined by slope in the vascular response 
curves.  This relationship characterizes the dynamic responsiveness of any vascular bed to 
increased demand, a parameter that determines each person’s vascular reserve. This 
observation is particularly important since most of the efforts to prevent CVD are currently 
  9
focused on modifying population risk factors that often either over- or underestimate 
individualized risk (Cohn 2013). The assessment of the dynamic retinal vascular response to 
flicker represents a non-invasive way to determine the individual’s functional vascular 
capacity and, therefore, the individual’s likelihood to develop disease or to respond to 
vasoactive therapies currently used in treating CVD. Our observations could, therefore, 
suggest that individual vascular response profiles when used alongside traditional risk 
factors might improve the accuracy of CVD prediction (Akiyama et al. 2012; Matsuzawa et 
al. 2013). 
 
Additional results of the present study also disclosed a negative relationship between LDL-C 
and arterial and venous BDF. LDLs are particularly susceptible to oxidative modifications 
and oxidized low-density lipoproteins (ox-LDLs) can inhibit the synthesis and release of 
endothelial nitric oxide synthase (eNOS) resulting in the decreased bioavailability of NO 
(Rosendorff 2002), as well as the increased expression of endothelin-1 (ET-1) and adhesion 
molecules (Ou et al. 2010; Itabe et al. 2011); all of which further contribute to the down-
regulation of local retinal vascular tone and vessel stiffness (Laurent et al. 2005). On this 
basis, it could be hypothesized that the oxidative modification of LDL-C maybe associated 
with changes in the elastic properties of the vessel wall, reflected at the retinal vascular level 
as decreases in spontaneous variations of vessel diameter during normal resting conditions 
(Nagel &  Vilser 2004). Indeed, ox-LDLs have been shown to impair vasomotor function of 
the coronary microcirculation (Hein &  Kuo 1998). Moreover, LDL-C apheresis has been 
shown to improve endothelium-dependent vasodilation in hypercholesterolemic patients 
(Tamai et al. 1997), and to positively influence myocardial (Mellwig et al. 1998), cerebral 
(Rubba et al. 1993), and retinal (Terai et al. 2011) blood flow. A negative influence of LDL-C 
on the overall venous DA was also observed. Since retinal veins typically incite a more 
passive regulatory contribution to increases in blood flow (Kotliar et al. 2004), whether the 
overall decreases in DA may reflect the reconciliation of alterations in arterial outflow to the 
venous side via downstream autoregulatory mechanisms is unclear at present.  
 
In our groups no correlations between measures of systemic macrovascular integrity and 
retinal microvascular function abnormalities were found. Interestingly, this finding is in 
concordance with that of a number of recent studies which have similarly demonstrated no 
direct correlation between anomalies identified at the macro- and micro-vascular levels in 
various disease states (Arosio et al. 2007; Heitmar et al. 2011; Sandoo et al. 2011). In 
addition, while C-IMT is a marker for structural abnormalities our measured retinal vascular 
parameters assess function which is affected first in the course of CVD. It is possible that in 
individuals with higher CVD risk than those included in the present study a positive 
correlation between anomalies identified at the macro- and micro-vascular levels would 
become apparent. Nevertheless, early identification of individuals at risk for CVD should be 
done when the disease is subclinical and well before structural changes begin to appear. 
Indeed, vascular changes in various beds appear to have common determinants since 
retinal vascular calibres have been shown to be associated with renal function in apparently 
healthy subjects (Daien et al. 2013). With this in mind, the direct relationship observed 
between systemic anti-oxidative defence capacity, plasma markers for CVD risk, and retinal 
dynamic vascular responses in apparently healthy individuals points toward more complex 
mechanisms that regulate the vascular response to stress at this level. In addition, it shows 
that assessing the retinal microvascular response in individuals free of overt vascular 
disease, but with a certain degree of CVD risk that is either age-related or due to other 
variables included in the FRS, could be a very sensitive indicator of each individual’s specific 
risk. As molecular and imaging biomarkers drive the shift towards personalized medicine, 
retinal vessel reactivity can be used for profiling individualized vascular risk by providing an 
integrated and dynamic analysis of vascular function as a variable specific for each 
individual and, therefore, to be used in prediction, prevention, and personalised intervention.  
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Tables 
 
Table 1. Summary of clinical characteristics  
 Mean (SD)   
 
Variable 
Men  
[n=54] 
Women  
[n=48] p-value 
Age [years] 52 (8) 53 (7) 0.271 
SBP [mmHg] 124 (14) 120 (15) 0.149 
DBP [mmHg] 80 (10) 73 (11) 0.002* 
HR [bpm] 65 (9) 64 (7) 0.495 
IOP 14 (3) 14 (2) 0.904 
BMI [kg/m2] 27.05 (4.17) 25.56 (3.89) 0.070 
TG [mmol/L] 1.22 (0.55) 1.06 (0.34) 0.088 
CHOL [mmol/L] 4.47 (0.80) 5.05 (0.96) 0.001* 
HDL-C [mmol/L] 1.18 (0.36) 1.49 (0.37) <0.001* 
LDL-C [mmol/L] 2.74 (0.79) 3.07 (0.97) 0.056 
C-IMT [cm] 0.07 (0.01) 0.06 (0.01) 0.064 
FRS [%] 9.46 (5.94) 5.59 (4.35) <0.001* 
t-GSH [µmol/L] 1117 (772) 935 (643) 0.200 
GSSG [µmol/L] 85 (73) 61 (48) 0.030* 
GSH [µmol/L] 935 (713) 813 (586) 0.353 
Redox index [GSH: GSSG] 15 (11) 20 (22) 0.140 
 
 
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; IOP, intraocular pressure; BMI, body mass index; 
TG, triglycerides; CHOL, total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; C-IMT, 
carotid intima-media thickness; FRS, 10-year Framingham risk score for cardiovascular disease; t-GSH, total glutathione; GSSG, oxidized 
glutathione; GSH, reduced glutathione. t-test *p<0.05 was considered significant. 
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Table 2. Summary of retinal vascular function parameters as assessed by DVA 
 Mean (SD)   
 
 
Men  
[n=54] 
Women  
[n=48] p-value 
Arteries:    
BDF 5.45 (2.14) 6.08 (3.63) 0.282 
DA 8.05 (3.65) 7.77 (3.90) 0.704 
MD [%] 5.15 (2.42) 4.71 (2.69) 0.385 
tMD [seconds] 19 (6) 20 (8) 0.216 
tMC [seconds] 28 (8) 27 (10) 0.767 
SlopeAD 0.37 (0.24) 0.34 (0.25) 0.567 
SlopeAC -0.25 (0.11) -0.31 (0.20) 0.060 
SlopeAC, NU 1.15 (0.54) 1.02 (0.52) 0.195 
 
Veins:    
BDF 4.38 (1.77) 4.30 (2.26) 0.866 
DA 6.92 (2.93) 6.89 (2.94) 0.971 
MD [%] 7.54 (5.07) 5.85 (3.18) 0.060 
tMD [seconds] 20 (5) 22 (6) 0.099 
tMC [seconds] 31 (9) 30 (9) 0.587 
SlopeVD 0.32 (0.16) 0.49 (0.14) 0.408 
SlopeVC -0.23 (0.14) -0.24 (0.13) 0.135 
SlopeVC, NU 1.49 (0.74) 1.36 (0.61) 0.365 
 
Abbreviations: BDF, baseline diameter fluctuation (maximal range of baseline diameter measurements); DA, dilation amplitude (maximum 
diameter [MD] – minimum diameter [MC]); MD [%], percentage MD relative to baseline diameter; tMD, time taken to reach MD; tMC; time taken 
to reach MC from MD; SlopeAD/VD, slope of arterial/venous dilation (MD – baseline diameter) / tMD); SlopeAC/VC, slope of arterial/venous 
constriction (MC-MD / tMC); NU: normalized units. t-test/ANCOVA p<0.05 was considered significant. 
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Figure Legends  
 
 
Figure 1. Relationship between low-density lipoprotein levels on (A) retinal arterial baseline 
diameter fluctuation, (B) retinal venous baseline diameter fluctuation, and (C) venous dilation 
amplitude. Abbreviations: LDL-C, low-density lipoprotein cholesterol; BDF, baseline diameter 
fluctuation; DA, dilation amplitude.  
 
Figure 2. Relationship between the retinal arterial dilation response slope and redox index. 
Abbreviations: SlopeAD, retinal arterial dilation response slope; redox index, ratio of reduced 
glutathione (GSH) to oxidized glutathione (GSSG) levels.  
 
Figure 3. Relationship between the retinal arterial constriction response slope and (A) 
circulating reduced glutathione, (B) Framingham Risk Score. Abbreviations: SlopeAC, retinal 
arterial constriction response slope; GSH, reduced glutathione; FRS, 10-year Framingham 
Risk Score estimate for cardiovascular disease. Note: normalized unit values used on y-
axes.  
 
